195 related articles for article (PubMed ID: 28874254)
1. [The significance of HIV to bone mineral density].
Wessman M; Weis N; Katzenstein TL; Lebech AM; Thorsteinsson K; Hansen AE; Jensen JB
Ugeskr Laeger; 2017 Sep; 179(36):. PubMed ID: 28874254
[TBL] [Abstract][Full Text] [Related]
2. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
McGinty T; Mallon P
Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
[TBL] [Abstract][Full Text] [Related]
3. Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared With Men.
Erlandson KM; Lake JE; Sim M; Falutz J; Prado CM; Domingues da Silva AR; Brown TT; Guaraldi G
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):288-294. PubMed ID: 29140875
[TBL] [Abstract][Full Text] [Related]
4. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
Pinzone MR; Moreno S; Cacopardo B; Nunnari G
AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for evaluation and management of bone disease in HIV.
Brown TT; Hoy J; Borderi M; Guaraldi G; Renjifo B; Vescini F; Yin MT; Powderly WG
Clin Infect Dis; 2015 Apr; 60(8):1242-51. PubMed ID: 25609682
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density loss, osteoporosis, and fractures in HIV.
Labarga P
AIDS Rev; 2013; 15(3):189-90. PubMed ID: 24002203
[TBL] [Abstract][Full Text] [Related]
7. Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review.
Cortés YI; Yin MT; Reame NK
J Assoc Nurses AIDS Care; 2015; 26(4):387-98. PubMed ID: 26066693
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of bone mineral density measurement in menopausal woman: a study of 217 post menopausal women.
Ansari SM; Begum T; Siddique AB
Bangladesh Med Res Counc Bull; 2004 Apr; 30(1):25-30. PubMed ID: 15376466
[TBL] [Abstract][Full Text] [Related]
9. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.
Bonjoch A; Figueras M; Estany C; Perez-Alvarez N; Rosales J; del Rio L; di Gregorio S; Puig J; Gómez G; Clotet B; Negredo E;
AIDS; 2010 Nov; 24(18):2827-33. PubMed ID: 21045635
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Working towards an understanding of bone disease in HIV.
Brown TT; Mallon PW
Curr Opin HIV AIDS; 2016 May; 11(3):251-2. PubMed ID: 27045192
[No Abstract] [Full Text] [Related]
12. Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years.
Negredo E; Bonjoch A; Pérez-Álvarez N; Ornelas A; Puig J; Herrero C; Estany C; del Río L; di Gregorio S; Echeverría P; Clotet B
HIV Med; 2015 Aug; 16(7):441-8. PubMed ID: 25944411
[TBL] [Abstract][Full Text] [Related]
13. HIV infection and bone disease.
Compston J
J Intern Med; 2016 Oct; 280(4):350-8. PubMed ID: 27272530
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral abnormalities in persons with HIV infection: signal or noise?
Singh K; Moyle GJ
AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of antiretroviral therapy: focus on bone density.
Viganò A; Mora S
Expert Opin Drug Saf; 2004 May; 3(3):199-208. PubMed ID: 15155148
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic bone disorders in HIV patients].
Reisfeld S; Chowers M
Harefuah; 2013 Apr; 152(4):238-41, 245. PubMed ID: 23844528
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
Ito K; Blinder VS; Elkin EB
J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
[TBL] [Abstract][Full Text] [Related]
18. Frailty in HIV infected people: a new risk factor for bone mineral density loss.
Bregigeon S; Galinier A; Zaegel-Faucher O; Cano CE; Obry V; Laroche H; Trijau S; Saout A; Poizot-Martin I
AIDS; 2017 Jul; 31(11):1573-1577. PubMed ID: 28426535
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
[TBL] [Abstract][Full Text] [Related]
20. High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs.
Negredo E; Langohr K; Bonjoch A; Pérez-Alvárez N; Estany C; Puig J; Rosales J; Echeverría P; Clotet B; Gómez G
J Antimicrob Chemother; 2018 Sep; 73(9):2452-2459. PubMed ID: 29860519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
